Andrx Puts Branded Rx Line In Fast Lane: Ex-Bristol Exec Joins As CEO
Executive Summary
Andrx CEO Richard Lane will oversee the launch of the extended-release lovastatin formulation Altocor
You may also be interested in...
Andrx Reviewing Brand Strategy Ahead Of Fortamet Launch
Andrx will launch diabetes agent Fortamet (metformin extended-release) as it is reducing emphasis on branded product development and marketing
Andrx Reviewing Brand Strategy Ahead Of Fortamet Launch
Andrx will launch diabetes agent Fortamet (metformin extended-release) as it is reducing emphasis on branded product development and marketing
Andrx replaces CEO
Former Chesapeake Biological Labs CEO Thomas Rice replaces Richard Lane as Andrx' chief executive. Rice, who joined Andrx' board in April, says the change was "in no way associated with the company's finances, accounting or business conditions," but was aimed at accelerating implementation of strategic initiatives. Lane joined Andrx in June 2002 after leaving Bristol-Myers Squibb as part of a management change following disclosure of inventory problems (1"The Pink Sheet" May 27, 2002, p. 21)...